Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding
Others
Ratios

Applied Therapeutics (APLT) Revenue (2023 - 2025)

Historic Revenue for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $1.0 million.

  • Applied Therapeutics' Revenue rose 71967.21% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 59751.24%. This contributed to the annual value of $455000.0 for FY2024, which is 9544.68% down from last year.
  • According to the latest figures from Q3 2025, Applied Therapeutics' Revenue is $1.0 million, which was up 71967.21% from $122000.0 recorded in Q3 2024.
  • Applied Therapeutics' Revenue's 5-year high stood at $10.7 million during Q1 2023, with a 5-year trough of -$667000.0 in Q4 2023.
  • Over the past 3 years, Applied Therapeutics' median Revenue value was $172000.0 (recorded in 2024), while the average stood at $1.9 million.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 9812.38% in 2024, then skyrocketed by 71967.21% in 2025.
  • Over the past 3 years, Applied Therapeutics' Revenue (Quarter) stood at -$667000.0 in 2023, then surged by 118.29% to $122000.0 in 2024, then soared by 719.67% to $1.0 million in 2025.
  • Its Revenue was $1.0 million in Q3 2025, compared to $122000.0 in Q3 2024 and $144000.0 in Q2 2024.